← Back to Clinical Trials
Recruiting NCT05358067

NCT05358067 Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05358067
Status Recruiting
Phase
Sponsor Centre Hospitalier Arras
Condition Post-traumatic Stress Disorder
Study Type OBSERVATIONAL
Enrollment 241 participants
Start Date 2022-10-24
Primary Completion 2026-10-23

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 241 participants in total. It began in 2022-10-24 with a primary completion date of 2026-10-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to evaluate correlation between Clinical Global Impression Scale (CGI) score immediately in patients who have experienced psychotrauma and occurrence of posttraumatic stress disorder at distance from traumatic event. This could allow, in future, implementation of a systematic telephone reminder of psychotraumatized patients when they have a high score on the CGI scale, and thus detect onset of a stress disorder as early as possible, post-traumatic and orientation of these patients on specialized care.

Eligibility Criteria

Inclusion Criteria: * Patient who has experienced a traumatic event in the last 48 hours; * Patient speaking French; Exclusion Criteria: * Patient participating in another clinical trial on the treatment of his psychotraumatic experience. * Person deprived of liberty (prisoners, defendants); * Persons under legal protection (protected adults: under guardianship, curatorship, etc.); * Opposition of the patient to participate in the research.

Contact & Investigator

Central Contact

Kathleen JACQUEZ, MSC

✉ kathleen.jacquez@gh-artoisternois.fr

📞 03 21 21 15 99

Frequently Asked Questions

Who can join the NCT05358067 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Post-traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05358067 currently recruiting?

Yes, NCT05358067 is actively recruiting participants. Contact the research team at kathleen.jacquez@gh-artoisternois.fr for enrollment information.

Where is the NCT05358067 trial being conducted?

This trial is being conducted at Arras, France, Arras, France, Douai, France, Lens, France and 1 additional location.

Who is sponsoring the NCT05358067 clinical trial?

NCT05358067 is sponsored by Centre Hospitalier Arras. The trial plans to enroll 241 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology